BeOne Medicines (ONC) Cash from Investing Activities Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 38.24% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -22.09% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 30.54% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | -29.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.84% |
| Dec 31, 2025 | -44.14% |
| Sep 30, 2025 | -31.82% |
| Jun 30, 2025 | -28.08% |
| Mar 31, 2025 | -37.15% |
| Dec 31, 2024 | -64.03% |
| Sep 30, 2024 | -123.48% |
| Jun 30, 2024 | -34.65% |
| Mar 31, 2024 | -39.57% |
| Dec 31, 2023 | 10.37% |
| Sep 30, 2023 | 50.51% |
| Jun 30, 2023 | 29.22% |
| Mar 31, 2023 | 30.38% |
| Dec 31, 2022 | 53.45% |
| Sep 30, 2022 | -7.43% |
| Jun 30, 2022 | 50.82% |
| Mar 31, 2022 | 6.86% |
| Dec 31, 2021 | -28.05% |
| Sep 30, 2021 | 70.98% |
| Jun 30, 2021 | 94.62% |
| Mar 31, 2021 | 39.94% |
| Dec 31, 2020 | -8.40% |
| Sep 30, 2020 | -56.44% |
| Jun 30, 2020 | -101.38% |
| Mar 31, 2020 | -202.23% |
| Dec 31, 2019 | 48.08% |
| Sep 30, 2019 | 69.23% |
| Jun 30, 2019 | 50.61% |
| Mar 31, 2019 | 62.28% |
| Dec 31, 2018 | 207.95% |
| Sep 30, 2018 | -331.70% |
| Jun 30, 2018 | 34.83% |
| Mar 31, 2018 | -398.73% |